Fox Chase Cancer Center | Philadelphia, PA
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to assess the safety and tolerability of BMS-986406 administered alone, in combination with nivolumab, or in combination with nivolumab and platinum-doublet chemotherapy (PDCT) in participants with advanced tumors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Parts 1A, 1B, 1C:
Part 1D:
All Parts:
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria apply
Primary purpose
Allocation
Interventional model
Masking
154 participants in 5 patient groups
Loading...
Central trial contact
First line of email MUST contain NCT # and Site #.; BMS Study Connect Contact Center www.BMSStudyConnect.com
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal